Abbott Laboratories v Corbridge Group Pty Ltd
[2000] FCA 1713
At a glance
Source factsCourt
Federal Court of Australia
Decision date
2000-11-24
Before
Gyles J
Source
Original judgment source is linked above.
Judgment (11 paragraphs)
REASONS FOR JUDGMENT 1 The first applicant, Abbott Laboratories ("Abbott") is the registered proprietor of Australian patent number 572138 ("the patent"), and the second applicant, Abbott Australasia Pty Limited ("Abbott Australia") is a licensee of Abbott in Australia. 2 The first respondent, Corbridge Group Pty Limited ("Corbridge") has imported for sale and supplied in Australia quantities of the product known as the "Excel ET blood glucose test strip" ("the Selfcare strip"). The second respondent, Selfcare Pty Limited ("Selfcare Australia") sponsored that importation and supply of the Selfcare strip into Australia by Corbridge and thereby authorised the importation and sale of the product. 3 The applicants claim that the Selfcare strip infringes the patent and seek injunctive and monetary relief. This is denied, and Corbridge and Selfcare Australia have cross-claimed for revocation of the patent by reason of invalidity. There is also a cross-claim for breach of ss 52 and 53 of the Trade Practices Act 1974 (Cth), and for breach of s 46 of the Trade Practices Act 1974 (Cth). 4 The Selfcare strip is designed to be used in conjunction with an electronic meter made by the applicants ("the Exactech meter") for the measurement of glucose in blood. Those meters are distributed to members of the public who suffer from diabetes so that they can test their blood glucose levels as and when required. 5 The description of the Selfcare strip in the applicants' submissions suffices to explain it for present purposes: (a) It is a rectangular shaped plastic strip on which there are two electrodes. (b) The first of the electrodes is a working electrode which includes, inter alia, the enzyme glucose oxidase, a mediator compound and carbon, an electrically conductive material. (c) The second electrode functions as a reference electrode and consists of silver and silver chloride. (d) The two electrodes on the strip are not in physical or electrical contact. Each terminates in a contact at that end of the strip which is intended to be inserted into the applicants' Exactech meter. (e) When a drop of blood is placed on the Selfcare strip in contact with both of the electrodes it becomes an electrochemical cell. (f) Within the electrochemical cell glucose oxidase, as a constituent material of the working electrode and operating as an enzyme catalytic of glucose, transfers electrons from glucose in the blood to the mediator compound, which is also a constituent of the working electrode. (g) In use, when a voltage is applied across the two electrodes by the Exactech meter, the mediator compound transfers its charge to the carbon included in the working electrode. The resultant current flows around the completed circuit made by the two electrodes, the blood with which they are in contact and the circuitry of the Exactech meter; (h) when current flows around the circuit in that manner, the Exactech meter gives a reading which reflects the concentration of glucose in the blood previously applied to the strip. 6 There is no controversy as to the physical configuration of the Selfcare strip. The dispute turns on the proper construction of the claims of the patent which are relied upon. The applicants plead that five claims of the patent (each being a product claim) are infringed. As there is no separate dispute about claims 22 and 23, argument has concentrated upon claims 1, 3 and 19. Although not in suit, claim 4 is relevant to the argument. Claims 1, 3, 4 and 19 are as follows: "Claim 1: